Brief: Bioaffinity Technologies Announces Acceptance Of Patent Application For Early-Stage Lung Cancer Diagnostic

BioAffinity Technologies

22/01/2025 14:22

Jan 22 (Reuters) - bioAffinity Technologies Inc
 BIAF.O :
    * BIOAFFINITY TECHNOLOGIES ANNOUNCES ACCEPTANCE OF PATENT
APPLICATION FOR EARLY-STAGE LUNG CANCER DIAGNOSTIC
    * BIOAFFINITY TECHNOLOGIES INC - AUSTRALIAN PATENT FOR
CYPATH LUNG
TEST TO EXPIRE IN 2042

Source text:  ID:nBw6fQqrCa 
Further company coverage:  BIAF.O